Acquired coagulation disorders: Revisited using global coagulation/ anticoagulation testing

Armando Tripodi, Veena Chantarangkul, Pier M. Mannucci

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Acquired coagulation defects are characterized by a decrease of both pro- and anti-coagulants. Because of this, we hypothesise that global tests, such as the prothrombin and partial thromboplastin times (PT and APTT), might be unsuitable for their investigation. Indeed, these tests are not good predictors of bleeding in acquired coagulopathies as they are in the congenital ones. This article discusses the possible reasons for this, using cirrhosis and the neonatal period as epitomes of acquired coagulation defects. Both display normal thrombin generation in the presence of thrombomodulin, in spite of prolonged PT and APTT. We surmise that, because of their design, the PT and APTT are responsive to thrombin generated as a function of pro-coagulants, but much less to thrombin inhibited by the anti-coagulants, especially protein C, which is activated to a limited extent in the absence of thrombomodulin. In conclusion, the PT and APTT can tell us whether or not a patient is deficient in one or more pro-coagulants, but not whether this deficiency is counterbalanced by a parallel deficiency of anti-coagulants. Thrombin generation assays are more suitable than PT and APTT for use in acquired coagulation defects.

Original languageEnglish
Pages (from-to)77-82
Number of pages6
JournalBritish Journal of Haematology
Volume147
Issue number1
DOIs
Publication statusPublished - Oct 2009

Fingerprint

Coagulants
Thrombin
Thrombomodulin
Partial Thromboplastin Time
Prothrombin
Protein C
Fibrosis
Hemorrhage

Keywords

  • Bleeding disorders
  • Coagulation factors
  • Liver disease
  • Neonatal haematology
  • Thrombin

ASJC Scopus subject areas

  • Hematology

Cite this

Acquired coagulation disorders : Revisited using global coagulation/ anticoagulation testing. / Tripodi, Armando; Chantarangkul, Veena; Mannucci, Pier M.

In: British Journal of Haematology, Vol. 147, No. 1, 10.2009, p. 77-82.

Research output: Contribution to journalArticle

@article{ae79230b64c640139eac916527caaadd,
title = "Acquired coagulation disorders: Revisited using global coagulation/ anticoagulation testing",
abstract = "Acquired coagulation defects are characterized by a decrease of both pro- and anti-coagulants. Because of this, we hypothesise that global tests, such as the prothrombin and partial thromboplastin times (PT and APTT), might be unsuitable for their investigation. Indeed, these tests are not good predictors of bleeding in acquired coagulopathies as they are in the congenital ones. This article discusses the possible reasons for this, using cirrhosis and the neonatal period as epitomes of acquired coagulation defects. Both display normal thrombin generation in the presence of thrombomodulin, in spite of prolonged PT and APTT. We surmise that, because of their design, the PT and APTT are responsive to thrombin generated as a function of pro-coagulants, but much less to thrombin inhibited by the anti-coagulants, especially protein C, which is activated to a limited extent in the absence of thrombomodulin. In conclusion, the PT and APTT can tell us whether or not a patient is deficient in one or more pro-coagulants, but not whether this deficiency is counterbalanced by a parallel deficiency of anti-coagulants. Thrombin generation assays are more suitable than PT and APTT for use in acquired coagulation defects.",
keywords = "Bleeding disorders, Coagulation factors, Liver disease, Neonatal haematology, Thrombin",
author = "Armando Tripodi and Veena Chantarangkul and Mannucci, {Pier M.}",
year = "2009",
month = "10",
doi = "10.1111/j.1365-2141.2009.07833.x",
language = "English",
volume = "147",
pages = "77--82",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",
number = "1",

}

TY - JOUR

T1 - Acquired coagulation disorders

T2 - Revisited using global coagulation/ anticoagulation testing

AU - Tripodi, Armando

AU - Chantarangkul, Veena

AU - Mannucci, Pier M.

PY - 2009/10

Y1 - 2009/10

N2 - Acquired coagulation defects are characterized by a decrease of both pro- and anti-coagulants. Because of this, we hypothesise that global tests, such as the prothrombin and partial thromboplastin times (PT and APTT), might be unsuitable for their investigation. Indeed, these tests are not good predictors of bleeding in acquired coagulopathies as they are in the congenital ones. This article discusses the possible reasons for this, using cirrhosis and the neonatal period as epitomes of acquired coagulation defects. Both display normal thrombin generation in the presence of thrombomodulin, in spite of prolonged PT and APTT. We surmise that, because of their design, the PT and APTT are responsive to thrombin generated as a function of pro-coagulants, but much less to thrombin inhibited by the anti-coagulants, especially protein C, which is activated to a limited extent in the absence of thrombomodulin. In conclusion, the PT and APTT can tell us whether or not a patient is deficient in one or more pro-coagulants, but not whether this deficiency is counterbalanced by a parallel deficiency of anti-coagulants. Thrombin generation assays are more suitable than PT and APTT for use in acquired coagulation defects.

AB - Acquired coagulation defects are characterized by a decrease of both pro- and anti-coagulants. Because of this, we hypothesise that global tests, such as the prothrombin and partial thromboplastin times (PT and APTT), might be unsuitable for their investigation. Indeed, these tests are not good predictors of bleeding in acquired coagulopathies as they are in the congenital ones. This article discusses the possible reasons for this, using cirrhosis and the neonatal period as epitomes of acquired coagulation defects. Both display normal thrombin generation in the presence of thrombomodulin, in spite of prolonged PT and APTT. We surmise that, because of their design, the PT and APTT are responsive to thrombin generated as a function of pro-coagulants, but much less to thrombin inhibited by the anti-coagulants, especially protein C, which is activated to a limited extent in the absence of thrombomodulin. In conclusion, the PT and APTT can tell us whether or not a patient is deficient in one or more pro-coagulants, but not whether this deficiency is counterbalanced by a parallel deficiency of anti-coagulants. Thrombin generation assays are more suitable than PT and APTT for use in acquired coagulation defects.

KW - Bleeding disorders

KW - Coagulation factors

KW - Liver disease

KW - Neonatal haematology

KW - Thrombin

UR - http://www.scopus.com/inward/record.url?scp=70349194473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349194473&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2009.07833.x

DO - 10.1111/j.1365-2141.2009.07833.x

M3 - Article

C2 - 19659548

AN - SCOPUS:70349194473

VL - 147

SP - 77

EP - 82

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 1

ER -